Cargando…
Case Report: Omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in an adolescent patient
Omadacycline is a novel tetracycline antibiotic that exhibits good in vitro antibacterial activity against atypical pathogens such as Mycoplasma pneumoniae. It is approved for the treatment of adults with community-acquired bacterial pneumonia. However, the safety and efficacy of omadacycline in ped...
Autores principales: | Xu, Limin, Fang, Changquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570831/ https://www.ncbi.nlm.nih.gov/pubmed/37842004 http://dx.doi.org/10.3389/fcimb.2023.1244398 |
Ejemplares similares
-
Increased Macrolide Resistance Rate of M3562 Mycoplasma pneumoniae Correlated With Macrolide Usage and Genotype Shifting
por: Wang, Yacui, et al.
Publicado: (2021) -
Novel mechanisms of macrolide resistance revealed by in vitro selection and genome analysis in Mycoplasma pneumoniae
por: Wang, Na, et al.
Publicado: (2023) -
The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic
por: Jiang, Ting-ting, et al.
Publicado: (2023) -
Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022) -
Case Report: Chlamydia psittaci pneumonia complicated by Guillain-Barré syndrome detected using metagenomic next-generation sequencing
por: Fang, Changquan, et al.
Publicado: (2023)